June 21, 2022
Chemotherapy-induced peripheral neuropathy or CIPN is caused by the heavy metals in these medications which strive to eradicate cancer cells, but may also cause significant nerve damage in the process.
The after-effects of this neuropathy can significantly diminish the patient’s quality of life, even after the cancer is gone.
A combination of studies has found that more than 50 percent of chemo patients suffer from CIPN, a tremendously painful condition that is famously difficult to treat with traditional medication, most commonly Cymbalta, Lyrica, or Gabapentin, and standard pain management strategies.
Dr. Kord Kober, associate professor, University of California, San Francisco.
It can also reduce the quality of life due to chronic tingling and numbness in the hands and feet. Mobility and other essential activities of daily living can become impossible.
These centers’ studies have confirmed that Calmare’s scrambler therapy produces significantly positive results in minimizing or even eliminating pain from chemotherapy treatment.
“The FDA cleared the Calmare MC-5A device specifically to treat patients with neuropathy as a result of chemotherapy,” says Dr. Michael Cooney.
“We have treated patients with CIPN since 2011 and have seen dramatically positive outcomes firsthand.”
These findings, reported by top U.S. cancer centers, serve as a light at the end of a long, dark tunnel of pain for our friends, family and colleagues living with the painful after-effects of chemotherapy treatment.
Contact our clinic for your no-fee consultation related to your post-chemotherapy treatment nerve pain or treatment-resistant neuropathic pain condition by calling (201) 933-4440 or email us privately at email@example.com and speak with our friendly and knowledgeable Calmare team.